These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 29405129)

  • 1. Nicotinamide: Mechanism of action and indications in dermatology.
    Bains P; Kaur M; Kaur J; Sharma S
    Indian J Dermatol Venereol Leprol; 2018; 84(2):234-237. PubMed ID: 29405129
    [No Abstract]   [Full Text] [Related]  

  • 2. Niacinamide - mechanisms of action and its topical use in dermatology.
    Wohlrab J; Kreft D
    Skin Pharmacol Physiol; 2014; 27(6):311-5. PubMed ID: 24993939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of nicotinamide in dermatology.
    Forbat E; Al-Niaimi F; Ali FR
    Clin Exp Dermatol; 2017 Mar; 42(2):137-144. PubMed ID: 28052374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotinamide in dermatology: a capsule summary.
    Namazi MR
    Int J Dermatol; 2007 Dec; 46(12):1229-31. PubMed ID: 18173513
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral nicotinamide reduces transepidermal water loss: a randomized controlled trial.
    Chen AC; Martin AJ; Dalziell RA; Halliday GM; Damian DL
    Br J Dermatol; 2016 Dec; 175(6):1363-1365. PubMed ID: 27062605
    [No Abstract]   [Full Text] [Related]  

  • 6. A review of nicotinamide: treatment of skin diseases and potential side effects.
    Rolfe HM
    J Cosmet Dermatol; 2014 Dec; 13(4):324-8. PubMed ID: 25399625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical nicotinamide prevents UV immunosuppression.
    Kim N; Yang A; Kirsner RS
    J Invest Dermatol; 2008 Feb; 128(2):250. PubMed ID: 18195737
    [No Abstract]   [Full Text] [Related]  

  • 8. Topical treatment of hyperpigmentation disorders.
    Rendon M; Horwitz S
    Ann Dermatol Venereol; 2012 Dec; 139 Suppl 4():S153-8. PubMed ID: 23522631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotinamide: An Update and Review of Safety & Differences from Niacin.
    Huber R; Wong A
    Skin Therapy Lett; 2020 Nov; 25(5):7-11. PubMed ID: 33196157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotinamide in dermatology and photoprotection.
    Surjana D; Damian DL
    Skinmed; 2011; 9(6):360-5. PubMed ID: 22256624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensives in dermatology Part I - Uses of antihypertensives in dermatology.
    Ranugha PSS; Betkerur JB
    Indian J Dermatol Venereol Leprol; 2018; 84(1):6-15. PubMed ID: 29271372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of recalcitrant subcorneal pustular dermatosis with oral nicotinamide.
    Yamaguchi Y; Oyama N; Koizumi H; Chino T; Hasegawa M
    J Dermatol; 2019 Nov; 46(11):e438-e440. PubMed ID: 31187880
    [No Abstract]   [Full Text] [Related]  

  • 13. Topical corticosteroids in dermatology.
    Mehta AB; Nadkarni NJ; Patil SP; Godse KV; Gautam M; Agarwal S
    Indian J Dermatol Venereol Leprol; 2016; 82(4):371-8. PubMed ID: 27279294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical treatments in dermatology still going strong.
    van de Kerkhof PC
    J Dermatolog Treat; 2010 May; 21(3):125. PubMed ID: 20394487
    [No Abstract]   [Full Text] [Related]  

  • 15. UV radiation-induced immunosuppression is greater in men and prevented by topical nicotinamide.
    Damian DL; Patterson CR; Stapelberg M; Park J; Barnetson RS; Halliday GM
    J Invest Dermatol; 2008 Feb; 128(2):447-54. PubMed ID: 17882270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical delivery of niacinamide: Influence of neat solvents.
    Iliopoulos F; Sil BC; Monjur Al Hossain ASM; Moore DJ; Lucas RA; Lane ME
    Int J Pharm; 2020 Apr; 579():119137. PubMed ID: 32057889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical 4% nicotinamide vs. 1% clindamycin in moderate inflammatory acne vulgaris.
    Khodaeiani E; Fouladi RF; Amirnia M; Saeidi M; Karimi ER
    Int J Dermatol; 2013 Aug; 52(8):999-1004. PubMed ID: 23786503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotinamide reduces photodynamic therapy-induced immunosuppression in humans.
    Thanos SM; Halliday GM; Damian DL
    Br J Dermatol; 2012 Sep; 167(3):631-6. PubMed ID: 22709272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel approach to manage skin toxicity caused by therapeutic agents targeting epidermal growth factor receptor.
    Campanati A; Berardi R; Onofri A; Pierantoni C; Conte I; Giuliodori K; Molinelli E; Marcucci F; Cascinu S; Offidani A
    Ann Oncol; 2012 Apr; 23(4):1081-2. PubMed ID: 22457259
    [No Abstract]   [Full Text] [Related]  

  • 20. Photodynamic therapy in dermatology. Shedding a different light on skin disease.
    Lui H; Anderson RR
    Arch Dermatol; 1992 Dec; 128(12):1631-6. PubMed ID: 1456759
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.